(Q36774168)

16 August 2017

1 reference

title

Why, when and how to initiate insulin therapy in patients with type 2 diabetes (English)

1 reference

16 August 2017

1 reference

1 reference

Tibaldi J

1

1 reference

PubMed ID

17394436

16 August 2017

Rakel RE

series ordinal

2

1 reference

16 August 2017

1 April 2007

1 reference

International Journal of Clinical Practice

16 August 2017

1 reference

16 August 2017

61

1 reference

16 August 2017

4

1 reference

16 August 2017

633-644

1 reference

Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002

16 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2007.01309.X

Shifting of care for diabetes from secondary to primary care, 1990-5: review of general practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2007.01309.X

Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2007.01309.X

Contributions of fasting and postprandial glucose to hemoglobin A1c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2007.01309.X

Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2007.01309.X

Management of diabetes-related hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2007.01309.X

Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2007.01309.X

Therapeutic options in development for management of diabetes: pharmacologic agents and new technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2007.01309.X

10.1111/J.1742-1241.2007.01309.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17394436